Acetyl-L-carnitine (ALCAR) appears on a lot of nerve supplement labels. It has genuine research behind it. It also illustrates a problem with capsule-based formulas better than any other ingredient — one that's worth understanding before you evaluate any panel.
ALCAR is an acetylated form of L-carnitine, an amino acid derivative your body produces. Carnitine's core job is transporting fatty acids into mitochondria to be burned for energy. The acetylated form crosses into nervous tissue more readily than plain carnitine.
Two proposed mechanisms. First, supporting mitochondrial energy production in nerve cells, which are metabolically demanding. Second, some research has explored effects on nerve fibre regeneration and pain signalling.
Trials have examined ALCAR in diabetic neuropathy and in chemotherapy-related neuropathy, looking at pain scores and nerve conduction measures. Findings are mixed but not nothing — there's a real research base here.
Here's where it gets practical. ALCAR studies typically use 1,000 to 3,000 mg per day — one to three grams — usually split across two or three doses.
This isn't an accusation against any particular product. It's a structural fact about the format.
If a once-daily capsule lists ALCAR, expect a fraction of the studied dose — perhaps 50–200 mg. That's ten to sixty times below trial levels.
Products genuinely delivering research-level ALCAR are typically dedicated single-ingredient products, taken as multiple large capsules or as powder.
This generalises. A one-capsule multi-ingredient formula faces a hard physical constraint: total capsule volume. The more ingredients on the label, the less room for any of them.
Which creates a genuine tension in supplement design. A long ingredient list looks more comprehensive and sells better — while mathematically guaranteeing that each ingredient is present in smaller amounts.
When you see an impressive list of eight or ten actives in a single daily capsule, that's the trade-off you're looking at. See our category comparison.
Not necessarily — but expectations should scale to the dose. A modest ALCAR amount alongside other ingredients isn't going to replicate a trial using three grams, and no honest page should imply it will.
ALCAR is generally well tolerated. Mild digestive upset is the most common report, and a "fishy" body odour occurs in some people at higher doses. Anyone with a seizure disorder or on thyroid medication should discuss it with a doctor first.
Read next: why you may have to ask for the panel at all.